Equities

Merchavia Holdings and Investments Ltd

MRHL:TLV

Merchavia Holdings and Investments Ltd

Actions
Real EstateReal Estate Investment and Services
  • Price (ILa)83.00
  • Today's Change0.00 / 0.00%
  • Shares traded82.84k
  • 1 Year change-28.76%
  • Beta0.4403
Data delayed at least 20 minutes, as of Jul 16 2024 15:24 BST.
More ▼
Improved Notifications for Markets Data Alerts
Improved Notifications for Markets Data Alerts
Want push notifications sent directly to your devices for equity price changes and breaking news stories? Let us know here.
 
Existing alertsView our existing alerts
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Merchavia Holdings and Investments Ltd, formerly NEPCO STAR LTD, is an Israel-based company. The Company sold its jewelry business in 2007 and rents out a commercial development that was developed by NEPCO STAR LTD. in 1993.

  • Revenue in ILS (TTM)460.00k
  • Net income in ILS-16.23m
  • Incorporated1972
  • Employees1.23k
  • Location
    Merchavia Holdings and Investments LtdMETSADA 7BNEI BRAK 5126112IsraelISR
  • Phone+972 35788770
  • Fax+972 774701479
  • Websitehttps://merchavia.com/
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
Univo Pharmaceuticals Ltd52.65m-32.19m3.06m12.00--0.1744--0.0582-10,833.61-10,833.6118,078.285,333.010.64062.1520.71---39.71-40.93-58.86-53.8628.88---61.99-95.670.6479-4.900.6719--25.38170.24-3,522.40--428.61--
HBL Hadasit Bio Holdings Ltd0.00-29.19m4.24m16.00--0.7135-----2.63-2.630.000.53540.00-------124.15-13.00-137.60-13.91-------100,517.40---0.0650.2098------6.48------
Merchavia Holdings and Investments Ltd460.00k-16.23m13.94m1.23k--0.4825--30.31-3.87-3.870.04091.720.0121--1.53374.59-42.78-3.37-43.98-3.46-----3,528.48-185.15---0.13460.00--90.08-10.25-349.99--37.97--
Nextage Therapeutics Ltd876.00k-4.07m21.29m--------24.31-0.1396-0.13960.03-0.09580.672--6.82---322.44-188.94---423.7625.6833.33-479.79-2,486.19---18.46------17.9927.21------
Kadimastem Ltd0.00-12.01m26.11m32.00---------1.22-1.220.00-1.040.00-------115.17-155.33-1,153.60-1,831.12-----------9.443.22------47.14---50.73--
Purple Biotech Ltd0.00-67.90m47.78m20.00--0.3811-----0.2679-0.26790.000.40860.00----0.00-40.57-37.24-47.99-41.28-------9,415.70----0.0098------8.25---28.45--
X T L Biopharmaceuticals Ltd1.64m-81.38m48.73m33.00--0.599--29.66-0.3695-0.36950.00750.14930.0192--0.701249,784.54-94.96-53.17-111.98-59.10---2.33-4,953.75-1,084.42----0.00---85.80---7.97---53.12--
Matricelf Ltd0.00-13.83m57.22m----2.12-----0.8777-0.87770.001.670.00-------39.69---42.80--------------0.0527-------10.77------
Data as of Jul 16 2024. Currency figures normalised to Merchavia Holdings and Investments Ltd's reporting currency: Israeli Shekel ILS
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.